文献速递创伤骨科关节外科

手术治疗股骨近端与远端假体周围骨折的并发症和死亡率如何?一项基于登记的研究

How Often Do Complications and Mortality Occur After Operatively Treated Periprosthetic Proximal and Distal Femoral Fractures? A Register-based Study.
PubMed 文献 · Clin Orthop Relat Res · 2023-04-10

该登记研究评估了芬兰某医院区2004年至2016年间手术治疗的279例假体周围股骨骨折患者(近端171例、远端108例),发现近端骨折年均发病率为每1000例THA植入者2.3例,远端为每1000例TKA植入者1.3例,两者发病率均呈上升趋势,且并发症、再手术和死亡率较高。

要点

  • 近端假体周围股骨骨折年均发病率为每1000例THA植入者2.3例,远端为每1000例TKA植入者1.3例。
  • 近端骨折10年主要并发症累积发生率为12.3%,远端为9.3%。
  • 近端骨折10年死亡累积发生率为47.3%,远端为67.8%。

核心结论

  • THA和TKA使用增加导致手术治疗的假体周围骨折发病率上升,未来翻修手术将增多。
  • 高龄、患者衰弱及常复杂的骨折类型与高并发症、再手术和死亡率相关。
  • 医疗系统必须为假体周围骨折翻修手术的大幅增加做好准备,这些事件对患者是病态事件,对医疗系统是昂贵负担。

研究设计与样本

  • 基于登记的队列研究,纳入2004年1月至2016年12月期间在芬兰某医院区唯一开展此类手术的医院接受翻修THA或TKA或任何股骨骨折手术的2259例患者。
  • 逐一评估所有2259例患者的X线片和病历,根据影像学发现和医疗记录制定纳入和排除标准,最终279例(12%)符合纳入标准,形成近端假体周围股骨骨折组(n=171)和远端假体周围股骨骨折组(n=108)。
  • 随访截至2019年12月或患者死亡;从芬兰关节置换登记处和芬兰医院出院登记处获取该医院区THA或TKA患者人数以计算人群发病率。
  • 证据等级为III级,治疗性研究。

主要发现

  • 近端假体周围股骨骨折年均发病率为每1000例THA植入者2.3±0.9例(95%CI 1.8至2.7),远端假体周围股骨骨折为每1000例TKA植入者1.3±0.6例(95%CI 1.0至1.7)。
  • 2004年至2016年间,近端假体周围股骨骨折发病率从每1000例关节置换1.6例增至3.8例(95%CI 1.8至2.8),远端从0.4例增至1.7例(95%CI 2.4至4.4)。
  • 近端假体周围股骨骨折年均人群发病率为每10万人年5.3±2.2例(95%CI 4.1至6.4),远端为3.4±1.7例(95%CI 2.5至4.4)。
  • 研究期间近端假体周围股骨骨折每10万人年发病率从3.2例增至8.9例(95%CI 3.9至6.6),远端从1.3例增至4.4例(95%CI 2.4至4.8)。

关键数值与推荐

  • 近端假体周围股骨骨折主要并发症累积发生率:1年8.8%(95%CI 5.1%至13.6%),10年12.3%(95%CI 7.5%至18.4%)。
  • 远端假体周围股骨骨折主要并发症累积发生率:1年7.4%(95%CI 3.5%至13.4%),10年9.3%(95%CI 4.7%至15.7%)。
  • 近端假体周围股骨骨折再手术累积发生率:1年10.5%(95%CI 6.5%至15.7%),10年13.5%(95%CI 8.9%至19.1%)。
  • 远端假体周围股骨骨折再手术累积发生率:1年8.3%(95%CI 4.1%至14.5%),10年13.8%(原文写作10%年,95%CI 7.8%至21.4%)。
  • 近端假体周围股骨骨折死亡累积发生率:1年8.2%(95%CI 4.7%至12.9%),10年47.3%(95%CI 38.1%至55.9%);远端假体周围股骨骨折死亡累积发生率:1年14.8%(95%CI 8.8%至22.2%),10年67.8%(95%CI 56.3%至76.9%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究期间手术患者的诊断和手术编码变化很大,且有些不准确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of periprosthetic femoral fractures is increasing because of an increasing number of primary THAs and TKAs. High rates of complications and mortality are associated with periprosthetic fractures, but few studies have evaluated and compared the population-based incidences of these events after fractures. QUESTIONS/PURPOSES: (1) What is the annual incidence of periprosthetic fractures treated with surgery in one hospital district in Finland? (2) How are those incidences changing over time? (3) What is the risk of complications, reoperations, and death after those injuries? METHODS: This register-based study evaluated 2259 patients who underwent revision THA or TKA or any surgery for a femoral fracture between January 2004 and December 2016 at the only hospital in our district where these types of operations are performed. During the study period, the diagnosis and operation codes of the operated-on patients varied greatly, and they were somewhat inaccurate. We thus evaluated radiographs of all 2259 patients one by one, and created inclusion and exclusion criteria based on radiologic findings and medical records. Of those, 12% (279 of 2259) had periprosthetic fractures that met the inclusion criteria, and from these, we formed two study groups (periprosthetic proximal femur fractures, n = 171; periprosthetic distal femur fractures, n = 108). Eighty-eight percent (1980 of 2259) of the patients were excluded because they were treated for a condition other than periprosthetic femoral fracture. The follow-up period ended in December 2019 or at the time the patient died. To evaluate the population-based incidence, we drew the number of individuals with THA or TKA in the hospital district from the Finnish Arthroplasty Register and the Finnish Hospital Discharge Register. The characteristics of patients with operatively treated periprosthetic femoral fractures were evaluated in terms of age, gender, fracture type, implant type, and time from the index operation to periprosthetic fracture. The annual incidences of periprosthetic femoral fractures are summarized per 1000 person-years of individuals living with an implanted THA or TKA and per 100,000 individuals per year living in our hospital district. The risks of death, complications, and reoperations were evaluated for both groups, and comparisons were made in terms of patient characteristics. RESULTS: The mean annual incidence of operatively treated periprosthetic proximal femur fractures per 1000 people living with THA implants was 2.3 ± 0.9 (95% confidence interval 1.8 to 2.7) per year, and for those with periprosthetic distal femur fractures with TKA implants, it was 1.3 ± 0.6 (95% CI 1.0 to 1.7). There was an increasing trend in the incidence of periprosthetic proximal femur fractures from 1.6 to 3.8 (95% CI 1.8 to 2.8) per 1000 arthroplasties, and it increased from 0.4 to 1.7 (95% CI 2.4 to 4.4) for periprosthetic distal femur fractures between 2004 and 2016. The mean population-based incidence of periprosthetic proximal femur fractures per 100,000 person-years was 5.3 ± 2.2 (95% CI 4.1 to 6.4) per year, and for periprosthetic distal femur fractures, it was 3.4 ± 1.7 (95% CI 2.5 to 4.4). The incidence of periprosthetic proximal femur fractures related to 100,000 person-years increased from 3.2 to 8.9 (95% CI 3.9 to 6.6), while the incidence of periprosthetic distal femur fractures increased from 1.3 to 4.4 (95% CI 2.4 to 4.8) during the study period. The cumulative incidence of major complications after periprosthetic proximal femur fracture was 8.8% at 1 year (95% CI 5.1% to 13.6%) and 12.3% at 10 years (95% CI 7.5% to 18.4%), and after periprosthetic distal femur fracture, it was 7.4% at 1 year (95% CI 3.5% to 13.4%) and 9.3% at 10 years (95% CI 4.7% to 15.7%). The cumulative incidence of reoperation after periprosthetic proximal femur fracture was 10.5% at 1 year (95% CI 6.5% to 15.7%) and 13.5% at 10 years (95% CI 8.9% to 19.1%), and for periprosthetic distal femur fracture, it was 8.3% at 1 year (95% CI 4.1% to 14.5%) and 13.8% at 10% years (95% CI 7.8% to 21.4%). The cumulative incidence of death after periprosthetic proximal femur fracture was 8.2% at 1 year (95% CI 4.7% to 12.9%) and 47.3% at 10 years (95% CI 38.1% to 55.9%), and after periprosthetic distal femur fractures, it was 14.8% at 1 year (95% CI 8.8% to 22.2%) and 67.8% at 10 years (95% CI 56.3% to 76.9%). CONCLUSION: The increased use of THA and TKA has led to an increase in the incidence of operatively treated periprosthetic fractures, which means there will be more revisions in the future. Older age, frailty of these patients, and often-complicated fracture patterns are related to a high rate of complications, reoperations, and mortality. Healthcare systems must prepare for a large increase in revisions for periprosthetic fracture, which are morbid events for patients and costly ones for healthcare systems. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Miettinen S, Sund R, Törmä S, et al. How Often Do Complications and Mortality Occur After Operatively Treated Periprosthetic Proximal and Distal Femoral Fractures? A Register-based Study. Clin Orthop Relat Res. 2023. PMID: 37036391. doi:10.1097/CORR.0000000000002638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。